We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Compared to Estimates, Teladoc (TDOC) Q2 Earnings: A Look at Key Metrics
Read MoreHide Full Article
Teladoc (TDOC - Free Report) reported $652.41 million in revenue for the quarter ended June 2023, representing a year-over-year increase of 10.1%. EPS of -$0.40 for the same period compares to -$0.44 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $649.02 million, representing a surprise of +0.52%. The company delivered an EPS surprise of +9.09%, with the consensus EPS estimate being -$0.44.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Teladoc performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
U.S. Integrated Care Members: 85.9 million compared to the 85.05 million average estimate based on six analysts.
BetterHelp Paying Users: 0.48 million compared to the 0.48 million average estimate based on six analysts.
Average Revenue Per U.S. Integrated Care Member: $1.41 compared to the $1.41 average estimate based on five analysts.
Chronic Care Enrollment: 1.07 million versus the five-analyst average estimate of 1.07 million.
Visits: 4700000 versus 5142163 estimated by three analysts on average.
Revenues by Segment- Teladoc Health Integrated Care: $360.05 million versus the eight-analyst average estimate of $358.08 million.
Revenues by Segment- BetterHelp: $292.36 million versus $290.58 million estimated by eight analysts on average.
Revenues by Segment- BetterHelp- Other Wellness Services: $4.07 million versus $3.69 million estimated by four analysts on average.
Revenues by Segment- BetterHelp- Therapy Services: $288.29 million versus $286.28 million estimated by four analysts on average.
Adjusted EBITDA- BetterHelp: $34.19 million compared to the $30.24 million average estimate based on six analysts.
Adjusted EBITDA- Teladoc Health Integrated Care: $37.97 million compared to the $35.07 million average estimate based on six analysts.
Shares of Teladoc have returned -2% over the past month versus the Zacks S&P 500 composite's +4.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Compared to Estimates, Teladoc (TDOC) Q2 Earnings: A Look at Key Metrics
Teladoc (TDOC - Free Report) reported $652.41 million in revenue for the quarter ended June 2023, representing a year-over-year increase of 10.1%. EPS of -$0.40 for the same period compares to -$0.44 a year ago.
The reported revenue compares to the Zacks Consensus Estimate of $649.02 million, representing a surprise of +0.52%. The company delivered an EPS surprise of +9.09%, with the consensus EPS estimate being -$0.44.
While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.
As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.
Here is how Teladoc performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:
- U.S. Integrated Care Members: 85.9 million compared to the 85.05 million average estimate based on six analysts.
- BetterHelp Paying Users: 0.48 million compared to the 0.48 million average estimate based on six analysts.
- Average Revenue Per U.S. Integrated Care Member: $1.41 compared to the $1.41 average estimate based on five analysts.
- Chronic Care Enrollment: 1.07 million versus the five-analyst average estimate of 1.07 million.
- Visits: 4700000 versus 5142163 estimated by three analysts on average.
- Revenues by Segment- Teladoc Health Integrated Care: $360.05 million versus the eight-analyst average estimate of $358.08 million.
- Revenues by Segment- BetterHelp: $292.36 million versus $290.58 million estimated by eight analysts on average.
- Revenues by Segment- BetterHelp- Other Wellness Services: $4.07 million versus $3.69 million estimated by four analysts on average.
- Revenues by Segment- BetterHelp- Therapy Services: $288.29 million versus $286.28 million estimated by four analysts on average.
- Adjusted EBITDA- BetterHelp: $34.19 million compared to the $30.24 million average estimate based on six analysts.
- Adjusted EBITDA- Teladoc Health Integrated Care: $37.97 million compared to the $35.07 million average estimate based on six analysts.
View all Key Company Metrics for Teladoc here>>>Shares of Teladoc have returned -2% over the past month versus the Zacks S&P 500 composite's +4.9% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.